Companies / Algeria
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
EIPICO Looks Abroad
June 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Egypt's unfavourable regulatory environment is forcing the Egyptian International Pharmaceutical Industries Company (EIPICO) to look abroad for growth, according to company chairman Ahmed Borhan El-Din Ismail. EIPICO is one of Egypt's largest drugmakers, with an 8% share of the country's US$1.75bn pharmaceutical market, so BMI expects the threat to move some production overseas to be taken seriously by a government that puts a strong emphasis on local